Resultats de la cerca - SATO, YASUYOSHI
- Mostrar 1 - 15 resultats de 15
-
1
-
2
-
3
Selection of RNA-based evaluation methods for tumor microenvironment by comparing with histochemical and flow cytometric analyses in gastric cancer per Saito, Noriyuki, Sato, Yasuyoshi, Abe, Hiroyuki, Wada, Ikuo, Kobayashi, Yukari, Nagaoka, Koji, Kushihara, Yoshihiro, Ushiku, Tetsuo, Seto, Yasuyuki, Kakimi, Kazuhiro
Publicat 2022Text -
4
Sequential Analysis of Neutrophil-to-lymphocyte Ratio for Differentiated Thyroid Cancer Patients Treated With Lenvatinib per FUKUDA, NAOKI, WANG, XIAOFEI, OHMOTO, AKIHIRO, URASAKI, TETSUYA, SATO, YASUYOSHI, NAKANO, KENJI, NISHIZAWA, MASATOSHI, YUNOKAWA, MAYU, ONO, MAKIKO, TOMOMATSU, JUNICHI, TAKAHASHI, SHUNJI
Publicat 2020Text -
5
Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck Cancer per SATO, YASUYOSHI, FUKUDA, NAOKI, FUJIWARA, YU, WANG, XIAOFEI, URASAKI, TETSUYA, OHMOTO, AKIHIRO, NAKANO, KENJI, ONO, MAKIKO, TOMOMATSU, JUNICHI, MITANI, HIROKI, TAKAHASHI, SHUNJI
Publicat 2021Text -
6
Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 Trial per Sato, Yasuyoshi, Fukuda, Naoki, Wang, Xiaofei, Urasaki, Tetsuya, Ohmoto, Akihiro, Nakano, Kenji, Yunokawa, Mayu, Ono, Makiko, Sato, Yukiko, Mitani, Hiroki, Tomomatsu, Junichi, Takahashi, Shunji
Publicat 2020Text -
7
Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients per Fukuda, Naoki, Yunokawa, Mayu, Fujiwara, Yu, Wang, Xiaofei, Ohmoto, Akihiro, Hayashi, Naomi, Urasaki, Tetsuya, Sato, Yasuyoshi, Nakano, Kenji, Ono, Makiko, Tomomatsu, Junichi, Mitani, Hiroki, Takahashi, Shunji
Publicat 2020Text -
8
Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib per FUKUDA, NAOKI, TODA, KAZUHISA, FUJIWARA, YU, WANG, XIAOFEI, OHMOTO, AKIHIRO, URASAKI, TETSUYA, HAYASHI, NAOMI, SATO, YASUYOSHI, NAKANO, KENJI, YUNOKAWA, MAYU, ONO, MAKIKO, TOMOMATSU, JUNICHI, MITANI, HIROKI, TAKAHASHI, SHUNJI
Publicat 2020Text -
9
Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy per Hayashi, Naomi, Sato, Yasuyoshi, Fujiwara, Yu, Fukuda, Naoki, Wang, Xiaofei, Nakano, Kenji, Urasaki, Testuya, Ohmoto, Akihiro, Ono, Makiko, Tomomatsu, Junichi, Sato, Yukiko, Mitani, Hiroki, Toshiyasu, Takashi, Takahashi, Shunji
Publicat 2021Text -
10
Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line per Nakano, Kenji, Hayakawa, Keiko, Funauchi, Yuki, Tanizawa, Taisuke, Ae, Keisuke, Matsumoto, Seiichi, Tomomatsu, Junichi, Ono, Makiko, Taira, Shinichiro, Nishizawa, Masatoshi, Wang, Xiaofei, Ohmoto, Akihiro, Sato, Yasuyoshi, Fukuda, Naoki, Urasaki, Tetsuya, Takahashi, Shunji
Publicat 2021Text -
11
Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma per Ohmoto, Akihiro, Sato, Yukiko, Asaka, Reimi, Fukuda, Naoki, Wang, Xiaofei, Urasaki, Tetsuya, Hayashi, Naomi, Sato, Yasuyoshi, Nakano, Kenji, Yunokawa, Mayu, Ono, Makiko, Tomomatsu, Junichi, Toshiyasu, Takashi, Mitani, Hiroki, Takeuchi, Kengo, Mori, Seiichi, Takahashi, Shunji
Publicat 2021Text -
12
Changes in Neutrophil-to-lymphocyte Ratio Predict Efficacy of Trabectedin for Soft-tissue Sarcoma per SATO, YASUYOSHI, NAKANO, KENJI, KAWAGUCHI, KUNIKI, FUKUDA, NAOKI, WANG, XIAOFEI, URASAKI, TETSUYA, OHMOTO, AKIHIRO, HAYASHI, NAOMI, YUNOKAWA, MAYU, ONO, MAKIKO, TOMOMATSU, JUNICHI, HAYAKAWA, KEIKO, FUNAUCHI, YUKI, TANIZAWA, TAISUKE, AE, KEISUKE, MATSUMOTO, SEIICHI, TAKAHASHI, SHUNJI
Publicat 2021Text -
13
Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma per Sato, Yasuyoshi, Nakano, Kenji, Wang, Xiaofei, Fukuda, Naoki, Urasaki, Tetsuya, Ohmoto, Akihiro, Hayashi, Naomi, Yunokawa, Mayu, Ono, Makiko, Tomomatsu, Junichi, Saito, Masanori, Minami, Yusuke, Hayakawa, Keiko, Funauchi, Yuki, Tanizawa, Taisuke, Ae, Keisuke, Matsumoto, Seiichi, Takahashi, Shunji
Publicat 2021Text -
14
Integrative immunogenomic analysis of gastric cancer dictates novel immunological classification and the functional status of tumor‐infiltrating cells per Sato, Yasuyoshi, Wada, Ikuo, Odaira, Kosuke, Hosoi, Akihiro, Kobayashi, Yukari, Nagaoka, Koji, Karasaki, Takahiro, Matsushita, Hirokazu, Yagi, Koichi, Yamashita, Hiroharu, Fujita, Masashi, Watanabe, Shuichi, Kamatani, Takashi, Miya, Fuyuki, Mineno, Junichi, Nakagawa, Hidewaki, Tsunoda, Tatsuhiko, Takahashi, Shunji, Seto, Yasuyuki, Kakimi, Kazuhiro
Publicat 2020Text -
15
Screening for COVID-19 in Symptomatic Cancer Patients in a Cancer Hospital per Fujiwara, Yu, Sato, Yasuyoshi, Wang, Xiaofei, Oikado, Katsunori, Sato, Yoshinao, Fukuda, Naoki, Enokida, Taisuke, Takeda, Koichi, Ohkushi, Daisuke, Hayama, Brian, Egi, Yoko, Tokai, Yoshitaka, Yamada, Yumi, Nakajima, Yuki, Kubota, Motoko, Haruki, Satomi, Shimizu, Takako, Uchida, Yasuko, Utsugi, Kuniko, Ito, Yoshinori, Ohno, Shinji, Takahashi, Shunji, Tsuchida, Tomohiro
Publicat 2020Text